SynthesisCardiovascular diabetology2017

Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes.

Zeqing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.